The China Mail - US authorizes first condom for use in anal sex

USD -
AED 3.67232
AFN 69.582255
ALL 84.918051
AMD 381.989449
ANG 1.789623
AOA 916.00015
ARS 1182.2858
AUD 1.538746
AWG 1.8025
AZN 1.701725
BAM 1.695631
BBD 2.013828
BDT 121.888099
BGN 1.69545
BHD 0.377101
BIF 2969.77342
BMD 1
BND 1.281021
BOB 6.892456
BRL 5.546602
BSD 0.997429
BTN 85.827608
BWP 13.406562
BYN 3.264022
BYR 19600
BZD 2.003511
CAD 1.358395
CDF 2877.000247
CHF 0.811405
CLF 0.024433
CLP 937.593041
CNY 7.181597
CNH 7.184425
COP 4133.49
CRC 502.750432
CUC 1
CUP 26.5
CVE 95.597064
CZK 21.462983
DJF 177.611132
DKK 6.45438
DOP 58.90997
DZD 130.113113
EGP 50.609904
ERN 15
ETB 134.56173
EUR 0.86534
FJD 2.24575
FKP 0.736284
GBP 0.73676
GEL 2.739779
GGP 0.736284
GHS 10.273661
GIP 0.736284
GMD 70.49708
GNF 8642.729885
GTQ 7.664931
GYD 208.681027
HKD 7.84968
HNL 26.032225
HRK 6.518029
HTG 130.80701
HUF 348.181496
IDR 16295.1
ILS 3.55795
IMP 0.736284
INR 86.075902
IQD 1306.607597
IRR 42099.999706
ISK 124.579968
JEP 0.736284
JMD 159.696905
JOD 0.70899
JPY 144.043002
KES 128.867253
KGS 87.450149
KHR 3999.323765
KMF 426.533153
KPW 900
KRW 1361.069844
KWD 0.30593
KYD 0.831155
KZT 511.588995
LAK 21520.375564
LBP 89366.224962
LKR 298.647987
LRD 199.484167
LSL 17.949916
LTL 2.95274
LVL 0.60489
LYD 5.44962
MAD 9.119803
MDL 17.080413
MGA 4503.821096
MKD 53.236364
MMK 2099.907788
MNT 3581.247911
MOP 8.063844
MRU 39.597557
MUR 45.490459
MVR 15.405002
MWK 1729.48464
MXN 18.92442
MYR 4.244008
MZN 63.950363
NAD 17.949916
NGN 1545.490059
NIO 36.70711
NOK 9.900605
NPR 137.326554
NZD 1.659076
OMR 0.384498
PAB 0.997455
PEN 3.600203
PGK 4.166612
PHP 56.502971
PKR 282.765147
PLN 3.693896
PYG 7958.560003
QAR 3.638523
RON 4.348202
RSD 101.402976
RUB 79.502451
RWF 1440.294076
SAR 3.754305
SBD 8.347391
SCR 14.228557
SDG 600.501551
SEK 9.49724
SGD 1.281215
SHP 0.785843
SLE 22.050262
SLL 20969.503664
SOS 570.036456
SRD 37.528023
STD 20697.981008
SVC 8.727692
SYP 13001.9038
SZL 17.938126
THB 32.458501
TJS 10.073996
TMT 3.5
TND 2.951358
TOP 2.342101
TRY 39.428965
TTD 6.763968
TWD 29.494965
TZS 2586.681991
UAH 41.37256
UGX 3594.480833
UYU 41.007946
UZS 12673.394368
VES 102.16696
VND 26091.5
VUV 119.102474
WST 2.619188
XAF 568.693783
XAG 0.027512
XAU 0.000293
XCD 2.70255
XDR 0.70726
XOF 568.693783
XPF 103.395062
YER 243.350268
ZAR 17.90752
ZMK 9001.199446
ZMW 24.112356
ZWL 321.999592
  • CMSC

    0.0900

    22.314

    +0.4%

  • CMSD

    0.0250

    22.285

    +0.11%

  • RBGPF

    0.0000

    69.04

    0%

  • SCS

    0.0400

    10.74

    +0.37%

  • RELX

    0.0300

    53

    +0.06%

  • RIO

    -0.1400

    59.33

    -0.24%

  • GSK

    0.1300

    41.45

    +0.31%

  • NGG

    0.2700

    71.48

    +0.38%

  • BP

    0.1750

    30.4

    +0.58%

  • BTI

    0.7150

    48.215

    +1.48%

  • BCC

    0.7900

    91.02

    +0.87%

  • JRI

    0.0200

    13.13

    +0.15%

  • VOD

    0.0100

    9.85

    +0.1%

  • BCE

    -0.0600

    22.445

    -0.27%

  • RYCEF

    0.1000

    12

    +0.83%

  • AZN

    -0.1200

    73.71

    -0.16%

US authorizes first condom for use in anal sex
US authorizes first condom for use in anal sex

US authorizes first condom for use in anal sex

The US Food and Drug Administration (FDA) on Wednesday authorized the first condom for use during anal intercourse, in what was hailed as a victory for sexual health by experts.

Text size:

Although people already use condoms for anal sex -- as is recommended by health agencies including the Centers for Disease Control and Prevention (CDC) -- regulators across the world had only previously allowed companies to officially market their products as "safe and effective" for vaginal use.

Sexual health advocates considered this an unmet public health need since unprotected anal intercourse carries the greatest risk of HIV transmission via sexual exposure, with one study finding that 69 percent of men who have sex with men would use condoms more frequently if they were FDA-indicated.

Wednesday's authorization of Global Protection Corp's One Male Condom follows a clinical trial involving more than 500 people, carried out by Emory University.

"The FDA's authorization of a condom that is specifically indicated, evaluated and labeled for anal intercourse may improve the likelihood of condom use during anal intercourse," said agency scientist Courtney Lias in a statement.

The condom is also indicated to prevent sexually transmitted infections -- and as a contraceptive -- during vaginal sex.

"We want people to have lots of sex -- but we also want them to be empowered and informed," said Davin Wedel, president of Global Protection Corp, which makes the condom brand that is available in 54 sizes, and incorporates a paper template to help each user find the right size.

The clinical trial involved 252 men who have sex with men and 252 men who have sex with women, aged between 18 and 54.

The FDA had said it would accept a five percent failure rate, which previous trials had failed to accomplish. The limit was easily surpassed in the new study, with the failure rate 0.68 percent for anal and 1.89 percent for vaginal intercourse.

The researchers behind the study, which was published in The Lancet's eClinicalMedicine, said one of the reasons the trial succeeded where others failed in the past was likely due to the provision of lubricant and inclusion of instructions on how to use the product.

Lubricant reduces friction, which in turn causes condom failure from slippage and breakage.

Another reason could be that participants were asked to keep mobile phone-based daily diaries, whereas past trials had asked volunteers to recall failure events up to several months later.

Monica Gandhi, an infectious disease doctor and medical director of an HIV clinic in San Francisco, welcomed the finding.

"The important thing about condoms is they don't just prevent HIV, but they prevent gonorrhea, chlamydia and syphilis," she told AFP, adding it was surprising that such an authorization had taken so long to achieve.

In its statement, the FDA said the green light could pave the way for more makers to apply for similar authorization if they show equivalent results.

D.Pan--ThChM